J&J | JNJ - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 42.1B 1.19B 2026-03
Abbott USD 18.38B 1.88B 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Baxter International USD 3.69B 723M 2026-03
Bayer EUR 33.46B 875M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Biogen USD 3B 350.5M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
CONMED USD 292.72M 22.32M 2026-03
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merck USD 26.94B 1.38B 2026-03
Merit Medical Systems USD 216.87M 22.89M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03
Zoetis USD 2.05B 182M 2026-03